Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Karen Oestergaard Pedersen has worked on the following 2 EPO patent applications which have been published in the last five years:

EP11779456

DOUBLE-ACYLATED GLP-1 DERIVATIVES

IPC classification:
A61K 47/48, A61P 3/10, C07K 14/605
Applicant:
Novo Nordisk A/S
Agent:
Karen Oestergaard Pedersen, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP12805429

GLP-1 DERIVATIVES

IPC classification:
A61K 38/26, C07K 14/605
Applicant:
Novo Nordisk A/S
Agent:
Karen Oestergaard Pedersen, Novo Nordisk A/S
Status:
PATENT GRANTED

Please Sign in to use this feature